Noteworthy new publications from the Congressional Research Service include the following.
The Impeachment Process in the House of Representatives, June 14, 2019
National Security Implications of Fifth Generation (5G) Mobile Technologies, CRS In Focus, June 12, 2019
U.S. Overseas Diplomatic Presence: Background and Issues for Congress, June 6, 2019
Maintaining Electric Reliability with Wind and Solar Sources: Background and Issues for Congress, June 10, 2019
Central American Migration: Root Causes and U.S. Policy, CRS In Focus, updated June 13, 2019
Extradition of U.S. Citizens, CRS Legal Sidebar, June 13, 2019
Regulating Big Tech: Legal Implications, CRS Legal Sidebar, June 11, 2019
Frequently Asked Questions about the Julian Assange Charges, CRS Legal Sidebar, updated June 7, 2019
Emergency Arms Sales to the Middle East: Context and Legislative History, CRS Memorandum, June 7, 2019
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.